China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D

SHANGHAI - China's essential drug system will hasten the consolidation of the generic industry while a measure for drug pricing will encourage innovation, according to a Frost & Sullivan report on the impact of China's healthcare reform, released May 18